수의 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global veterinary diagnostics market size is expected to reach USD 21.41 Billion in 2034 from USD 9.26 Billion in 2025, growing at a CAGR of 9.76% during 2026-2034.This market is expanding as pet ownership increases and livestock producers place greater emphasis on animal health, disease prevention, and productivity. Veterinary diagnostics enable early identification of infectious diseases, metabolic disorders, genetic conditions, and other health problems, supporting timely treatment and better outcomes. Growing spending on companion animal healthcare is encouraging veterinary clinics to adopt advanced diagnostic technologies. At the same time, livestock producers are seeking reliable testing solutions to minimize disease-related losses and maintain productivity. Increasing awareness of preventive veterinary care is further supporting demand for diagnostic services and equipment.

Technological advancements are creating new growth opportunities through faster, more accurate, and increasingly decentralized testing. Molecular diagnostics, immunoassays, imaging technologies, laboratory testing, and point-of-care platforms are becoming more accessible to veterinary professionals. Rising concerns about zoonotic diseases and antimicrobial resistance are also increasing the importance of accurate diagnosis before treatment. Digital veterinary platforms and connected diagnostic systems can improve data management and clinical decision-making. Growing investment in animal health infrastructure across emerging markets is expected to expand adoption, while demand for livestock disease surveillance is encouraging governments and producers to strengthen testing capabilities.

The future outlook is positive as veterinary healthcare continues shifting toward prevention, early detection, and personalized treatment. Companion animals are increasingly viewed as family members, supporting higher spending on advanced diagnostic services. In livestock, disease surveillance and biosecurity programs should drive continued demand for reliable testing. Artificial intelligence, automated laboratory systems, portable diagnostics, and digital health platforms may further improve diagnostic speed and accessibility. Manufacturers that provide cost-effective, accurate, and user-friendly solutions are likely to benefit. Strategic partnerships between diagnostic companies, veterinary clinics, laboratories, and animal health organizations should support continued market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits and Reagents
• Software and Services

By Technology

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Other Technologies

By Animal Type

• Companion Animals (Dogs, Cats, Other Companion Animals)
• Livestock Animals (Cattle, Swine, Poultry, Other Livestock Animals)

By End User

• Veterinary Hospitals & Clinics
• Reference Laboratories
• Ambulatory & Mobile Vet Services
• Research Institutes & Universities

COMPANIES PROFILED

• BioChek BV, BioMerieux SA, BioNote Inc., Bio-Rad Laboratories Inc., Boehringer Ingelheim GmbH, Covetrus Inc., Danaher Corporation, Esaote SpA, Heska Corporation, IDEXX Laboratories Inc., IDVet, INDICAL Bioscience GmbH, Mindray Medical International Ltd., Neogen Corporation, QIAGEN N.V., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac SA, Zoetis Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits and Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinical Biochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Companion Animals (Dogs, Cats, Other Companion Animals) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Livestock Animals (Cattle, Swine, Poultry, Other Livestock Animals) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Ambulatory & Mobile Vet Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research Institutes & Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Technology
  • 8.2.3 By Animal Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Technology
  • 8.3.3 By Animal Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Technology
  • 8.4.3 By Animal Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Technology
  • 8.5.3 By Animal Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Technology
  • 8.6.3 By Animal Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BioChek BV
  • 10.2.2 BioMerieux SA
  • 10.2.3 BioNote Inc
  • 10.2.4 Bio-Rad Laboratories Inc
  • 10.2.5 Boehringer Ingelheim GmbH
  • 10.2.6 Covetrus Inc
  • 10.2.7 Danaher Corporation
  • 10.2.8 Esaote SpA
  • 10.2.9 Heska Corporation
  • 10.2.10 IDEXX Laboratories Inc
  • 10.2.11 IDVet
  • 10.2.12 INDICAL Bioscience GmbH
  • 10.2.13 Mindray Medical International Ltd
  • 10.2.14 Neogen Corporation
  • 10.2.15 QIAGEN N.V
  • 10.2.16 Randox Laboratories Ltd
  • 10.2.17 Thermo Fisher Scientific Inc
  • 10.2.18 Virbac SA
  • 10.2.19 Zoetis Inc